Glaxosmithkline | GSK - Market Capitalization


Glaxosmithkline reported GBP106.21B in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 384.69B 19.14B Mar/2026
Amgen USD 189.89B 13.64B Mar/2026
AstraZeneca USD 301.25B 13.1B Mar/2026
Aurora Cannabis CAD 193.82M 133.39M Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Canopy Growth CAD 125.74M 431.39M Jul/2026
Corcept Therapeutics USD 4.32B 654M Mar/2026
Drreddys Laboratories INR 2.41B 8.66B Jul/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Glaxosmithkline GBP 108.55B 736M Jul/2026
J&J USD 595.26B 16.1B Jul/2026
Merck USD 297.1B 35.84B Mar/2026
Novartis USD 248.1B 59.65B Jul/2026
Pacira USD 915M 149M Mar/2026
Perrigo USD 1.31B 604M Mar/2026
Pfizer USD 153.81B 12.24B Mar/2026
Phibro Animal Health USD 1.51B 126M Dec/2025
Prestige Brands USD 2.8B 161M Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.27B 605.48M Mar/2026
Supernus Pharmaceuticals USD 2.98B 126M Mar/2026
Takeda JPY 9.01T 1.37T Mar/2026
Teva Pharmaceutical Industries USD 34.27B 2.14B Mar/2026
Zoetis USD 49.71B 5.74B Mar/2026